Literature DB >> 18587055

Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Todd M Bull1, Christina A Meadows, Christopher D Coldren, Mark Moore, Sylk M Sotto-Santiago, Serge P Nana-Sinkam, Thomas B Campbell, Mark W Geraci.   

Abstract

Human herpesvirus-8 (HHV-8) is the causative agent of Kaposi's sarcoma and is associated with the angioproliferative disorders primary effusion lymphoma and multicentric Castleman's disease. Evidence of HHV-8 infection within the pulmonary vasculature of patients with idiopathic pulmonary arterial hypertension (IPAH) has been described. We hypothesize that HHV-8 infection of pulmonary microvascular endothelial cells results in an apoptotic-resistant phenotype characteristic of severe pulmonary arterial hypertension. Our objective was to investigate the ability of HHV-8 to infect human pulmonary microvascular endothelial cells in vitro and characterize the phenotypic effect of this infection. Human pulmonary microvascular endothelial cells were exposed to HHV-8 using two methods (direct virus and co-culture technique). The presence of lytic and latent infection was confirmed. Changes in endothelial cell gene and protein expression and effects on cellular apoptosis were measured. HHV-8 can both lytically and latently infect primary human pulmonary microvascular endothelial cells in vitro. HHV-8 infection results in significant changes in gene expression, including alterations of pathways important to cellular apoptosis. HHV-8 infection also alters expression of genes integral to the bone morphogenic protein pathway, including down-regulation of bone morphogenic protein-4. Other genes previously implicated in the development of PAH are affected by HHV-8 infection, and cells infected with HHV-8 are resistant to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587055      PMCID: PMC2586046          DOI: 10.1165/rcmb.2007-0368OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  55 in total

1.  Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice.

Authors:  Scott M Golembeski; James West; Yuji Tada; Karen A Fagan
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

2.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients.

Authors:  W J Harrington; O Bagasra; C E Sosa; L E Bobroski; M Baum; X L Wen; L Cabral; G E Byrne; R J Pomerantz; C Wood
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension.

Authors:  A Scott Laney; Teresa De Marco; Jonathan S Peters; Mary Malloy; Carla Teehankee; Patrick S Moore; Yuan Chang
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

5.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.

Authors:  P Monini; S Colombini; M Stürzl; D Goletti; A Cafaro; C Sgadari; S Buttò; M Franco; P Leone; S Fais; P Leone; G Melucci-Vigo; C Chiozzini; F Carlini; G Ascherl; E Cornali; C Zietz; E Ramazzotti; F Ensoli; M Andreoni; P Pezzotti; G Rezza; R Yarchoan; R C Gallo; B Ensoli
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

6.  Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.

Authors:  H Lepetit; S Eddahibi; E Fadel; E Frisdal; C Munaut; A Noel; M Humbert; S Adnot; M-P D'Ortho; C Lafuma
Journal:  Eur Respir J       Date:  2005-05       Impact factor: 16.671

7.  Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.

Authors:  Xudong Yang; Lu Long; Mark Southwood; Nung Rudarakanchana; Paul D Upton; Trina K Jeffery; Carl Atkinson; Hailan Chen; Richard C Trembath; Nicholas W Morrell
Journal:  Circ Res       Date:  2005-04-21       Impact factor: 17.367

8.  Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients.

Authors:  Lauren Hammock; Amy Reisenauer; Wayne Wang; Cynthia Cohen; George Birdsong; Andrew L Folpe
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

9.  Pulmonary hypertension in rats. 2. Role of interleukin-6.

Authors:  M Miyata; F Sakuma; A Yoshimura; H Ishikawa; T Nishimaki; R Kasukawa
Journal:  Int Arch Allergy Immunol       Date:  1995-11       Impact factor: 2.749

Review 10.  Primary pulmonary hypertension between inflammation and cancer.

Authors:  N F Voelkel; C Cool; S D Lee; L Wright; M W Geraci; R M Tuder
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

View more
  12 in total

Review 1.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

2.  C19ORF66 Broadly Escapes Virus-Induced Endonuclease Cleavage and Restricts Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  William Rodriguez; Kumaraman Srivastav; Mandy Muller
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 3.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

4.  Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.

Authors:  Yuqing Li; Canrong Zhong; Dawei Liu; Wenjing Yu; Weikang Chen; Yan Wang; Songtao Shi; Yan Yuan
Journal:  Cancer Res       Date:  2017-10-24       Impact factor: 12.701

Review 5.  Shiftless, a Critical Piece of the Innate Immune Response to Viral Infection.

Authors:  William Rodriguez; Mandy Muller
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

6.  Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension.

Authors:  Fawad Ali; Arifullah Khan; Syed Aun Muhammad; Syed Qamar Abbas; Syed Shams Ul Hassan; Simona Bungau
Journal:  ACS Omega       Date:  2022-06-20

Review 7.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

8.  Osseous Metaplasia in Castleman's Disease: A Case Report.

Authors:  Maral Mokhtari; Perikala Vijayananda Kumar
Journal:  Case Rep Med       Date:  2012-05-09

9.  RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.

Authors:  For Yue Tso; Andrew V Kossenkov; Salum J Lidenge; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Jayamanna Wickramasinghe; Eun Hee Kwon; John T West; Paul M Lieberman; Charles Wood
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

10.  IRAV (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10.

Authors:  Corey A Balinsky; Hana Schmeisser; Alexandra I Wells; Sundar Ganesan; Tengchuan Jin; Kavita Singh; Kathryn C Zoon
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.